Rosetta Genomics Profile

USD 0.0056  0.88%
0.62Last Month High 0.78 
0.58Trading Day  High 0.64 

Rosetta Genomics Summary

Rosetta Genomics Ltd (ROSG) is traded on Nasdaq Capital Markets in USA. It is located in ISRAEL and employs 77 people. Rosetta Genomics is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Nano-Cap' category with current market capitalization of 3.6 M. Rosetta Genomics Ltd has 5.4 M outstanding shares of which 437.29 K shares are at this time shorted by private and institutional investors with about 6.64 trading days to cover. ROSETTA GENOMICS currently holds about 1.32 M in cash with (11.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.51.
Check Rosetta Genomics Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Selected Rosetta Genomics Ltd Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Rosetta Genomics Against Markets

Risk Adjusted
Performance Score (0 to 100)
Chance of
< 93% 
Rosetta Genomics Ltd. develops and commercializes microRNAbased and other molecular diagnostics. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameRosetta Genomics Ltd
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
Business AddressRosetta Genomics, Ltd.Rehovot,
ExchangeNasdaq Capital Markets
IndustryPharmaceutical Products
Contact Number972 73 222 0700
CurrencyUSD - US Dollar


Rosetta Genomics Analyst Recommendations
Target PriceAdvice# of Analysts
4.0Strong Buy4Odds
Rosetta Genomics Ltd current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Rosetta Genomics Analyst Advice  


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


Rosetta Genomics Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.16March 22, 2017
Rosetta Genomics Ltd normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate